Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 53 entries
View as:

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02091908 Org: User:
Start: 04/30/14 End: 04/30/15 Due: 04/30/16

A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.

Phase: N/A Priority: Normal
NCT ID: NCT02214225 Org: User:
Start: 08/31/14 End: 04/30/15 Due: 04/30/16

A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population

Phase: N/A Priority: Normal
NCT ID: NCT00959049 Org: User:
Start: 09/30/09 End: 05/31/10 Due: 05/31/11

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05501561 Org: User:
Start: 08/25/22 End: 03/31/23 Due: 03/31/24

Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years

Phase: N/A Priority: Normal
NCT ID: NCT00825162 Org: User:
Start: 03/31/09 End: 02/28/10 Due: 02/28/11

Phase II Study of Pandemic Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00320346 Org: User:
Start: 07/31/06 End: 09/30/06 Due: 09/30/07

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT04782323 Org: User:
Start: 04/13/21 End: 03/03/22 Due: 03/03/23

A Clinical Trial of CSL's 2010/2011 Formulation of Enzira® in a Healthy Adult Population

Phase: N/A Priority: Normal
NCT ID: NCT01113580 Org: User:
Start: 05/31/10 End: 05/31/10 Due: 05/31/11

Flucelvax Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT02258178 Org: User:
Start: 09/30/14 End: 06/30/20 Due: 06/30/21

Afluria Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT03442582 Org: User:
Start: 09/08/17 End: 09/14/21 Due: 09/14/22

Study of a Pandemic Influenza Vaccine in Elderly Participants

Phase: N/A Priority: Normal
NCT ID: NCT00376402 Org: User:
Start: 10/31/06 End: 06/30/07 Due: 06/30/08

A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

Phase: N/A Priority: Normal
NCT ID: NCT05422326 Org: User:
Start: 07/18/22 End: 03/24/23 Due: 03/24/24

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02587221 Org: User:
Start: 09/30/16 End: 07/23/18 Due: 07/23/19

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT03165617 Org: User:
Start: 05/25/17 End: 09/30/19 Due: 09/30/20

Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)

Phase: N/A Priority: Normal
NCT ID: NCT02583256 Org: User:
Start: 01/29/16 End: 05/09/17 Due: 05/09/18

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00938639 Org: User:
Start: 07/31/09 End: 03/31/10 Due: 03/31/11

Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04074928 Org: User:
Start: 09/06/19 End: 09/03/20 Due: 09/03/21

Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT00848848 Org: User:
Start: 10/31/08 End: 04/30/09 Due: 04/30/10

A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00562484 Org: User:
Start: 03/31/08 End: 01/31/10 Due: 01/31/11

Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old

Phase: N/A Priority: Normal
NCT ID: NCT02035696 Org: User:
Start: 12/31/13 End: 12/31/14 Due: 12/31/15

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02839330 Org: User:
Start: 07/11/16 End: 10/04/17 Due: 10/04/18

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT04576702 Org: User:
Start: 10/08/20 End: 05/24/21 Due: 05/24/22

An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older

Phase: N/A Priority: Normal
NCT ID: NCT04806529 Org: User:
Start: 12/15/20 End: 04/09/22 Due: 04/09/23

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT00940108 Org: User:
Start: 08/31/09 End: 04/30/10 Due: 04/30/11

Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

Phase: N/A Priority: Normal
NCT ID: NCT01964989 Org: User:
Start: 11/30/13 End: 08/31/16 Due: 08/31/17